Drug target ontology to classify and integrate drug discovery data

被引:0
|
作者
Yu Lin
Saurabh Mehta
Hande Küçük-McGinty
John Paul Turner
Dusica Vidovic
Michele Forlin
Amar Koleti
Dac-Trung Nguyen
Lars Juhl Jensen
Rajarshi Guha
Stephen L. Mathias
Oleg Ursu
Vasileios Stathias
Jianbin Duan
Nooshin Nabizadeh
Caty Chung
Christopher Mader
Ubbo Visser
Jeremy J. Yang
Cristian G. Bologa
Tudor I. Oprea
Stephan C. Schürer
机构
[1] Center for Computational Science,Department of Applied Chemistry
[2] University of Miami,Department of Internal Medicine, Translational Informatics Division
[3] Department of Computer Science,Department of Molecular and Cellular Pharmacology
[4] University of Miami,Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences
[5] Delhi Technological University,undefined
[6] University of New Mexico School of Medicine,undefined
[7] Miller School of Medicine,undefined
[8] University of Miami,undefined
[9] University of Copenhagen,undefined
[10] National Center for Advancing Translational Science,undefined
来源
Journal of Biomedical Semantics | / 8卷
关键词
Library Of Integrated Network-based Cellular Signatures (LINCS); Druggable Genome; Pharos; Chemical Entities Of Biological Interest (ChEBI); Vocabulary File;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Drug target ontology to classify and integrate drug discovery data
    Lin, Yu
    Mehta, Saurabh
    Kucuk-McGinty, Hande
    Turner, John Paul
    Vidovic, Dusica
    Forlin, Michele
    Koleti, Amar
    Dac-Trung Nguyen
    Jensen, Lars Juhl
    Guha, Rajarshi
    Mathias, Stephen L.
    Ursu, Oleg
    Stathias, Vasileios
    Duan, Jianbin
    Nabizadeh, Nooshin
    Chung, Caty
    Mader, Christopher
    Visser, Ubbo
    Yang, Jeremy J.
    Bologa, Cristian G.
    Oprea, Tudor I.
    Schurer, Stephan C.
    JOURNAL OF BIOMEDICAL SEMANTICS, 2017, 8
  • [2] PyMine: A PyMOL plugin to integrate and visualize data for drug discovery Bioinformatics
    Chaudhari R.
    Li Z.
    BMC Research Notes, 8 (1)
  • [3] Using ensembles to classify compounds for drug discovery
    Lanctot, JK
    Putta, S
    Lemmen, C
    Greene, J
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2003, 43 (06): : 2163 - 2169
  • [4] An Ontology for Description of Drug Discovery Investigations
    Qi, Da
    King, Ross D.
    Hopkins, Andrew L.
    Bickerton, G. Richard J.
    Soldatova, Larisa N.
    JOURNAL OF INTEGRATIVE BIOINFORMATICS, 2010, 7 (03):
  • [5] Drug-Target Kinetics in Drug Discovery
    Tonge, Peter J.
    ACS CHEMICAL NEUROSCIENCE, 2018, 9 (01): : 29 - 39
  • [6] Applications of drug-target data in translating genomic variation into drug discovery opportunities
    Gaulton, Anna
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [7] Target class drug discovery
    Kimberly D Barnash
    Lindsey I James
    Stephen V Frye
    Nature Chemical Biology, 2017, 13 : 1053 - 1056
  • [8] Proteomics for drug target discovery
    Gottfries, J
    Sjögren, M
    Holmberg, B
    Rosengren, L
    Davidsson, P
    Blennow, K
    CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 2004, 73 (01) : 47 - 53
  • [9] The adipocyte as a drug discovery target
    Nawrocki, AR
    Scherer, PE
    DRUG DISCOVERY TODAY, 2005, 10 (18) : 1219 - 1230
  • [10] Genomics in target and drug discovery
    van Duin, M
    Woolson, H
    Mallinson, D
    Black, D
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 429 - 432